Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective-Reference-Cited by-同舟云学术

Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective

Published:2022-02-01 Issue:5 Volume:61 Page:1748-1751
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Mehta Puja¹²^ORCID,Hoyles Rachel K³,Gunawardena Harsha⁴,Gooptu Bibek⁵,Chaudhuri Nazia⁶⁷,Heightmann Melissa J⁸^ORCID,Garthwaite Helen⁸,Penn Henry⁹,Datta Arnab¹⁰,Hamdulay Shahir⁹,Lams Boris¹¹,Agarwal Sangita¹²,Wickremesinghe Melissa¹³,Jenkins Gisli¹⁴,Porter Joanna C¹⁸,Denton Christopher P¹⁵^ORCID

Affiliation:

1. Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London

2. Department of Rheumatology, University College London Hospital (UCLH), London

3. Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford

4. Department of Rheumatology, North Bristol NHS Trust and University of Bristol, Bristol

5. Department of Respiratory Medicine, University of Leicester, Leicester

6. North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust

7. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester and Manchester University NHS Foundation Trust, Manchester

8. Department of Respiratory Medicine, University College London Hospital (UCLH)

9. Department of Rheumatology

10. Department of Respiratory Medicine, Northwick Park Hospital

11. Department of Respiratory Medicine

12. Department of Rheumatology, Guys and St Thomas’ Hospital

13. Department of Respiratory Medicine, Imperial College Healthcare NHS Trust

14. Department of Respiratory Medicine, Royal Brompton Hospital

15. Department of Rheumatology, Royal Free Hospital, London, UK

Funder

Medical Research Council

National Institute for Health Research

University College London Hospitals

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac061/42675630/keac061.pdf

Reference12 articles.

1. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases;Fischer;Clin Rheumatol,2019

2. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features;Fischer;Eur Respir J,2015

3. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias;Travis;Am J Respir Crit Care Med,2013

4. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society;Bradley;Thorax,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study;Archives of Rheumatology;2024-02-02

2. AB1483 CLINICAL OUTCOMES OF EXTRACORPOREAL LIFE SUPPORT AND LUNG TRANSPLANTATION IN SEVERE ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA5)-RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW;Scientific Abstracts;2023-05-30

3. AB1605 A PILOT RHEUMATOLOGY-INTERSTITIAL LUNG DISEASE (ILD) SERVICE - OUTCOMES AFTER 12 MONTHS;Scientific Abstracts;2023-05-30

4. Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians;Best Practice & Research Clinical Rheumatology;2022-06